TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹13 Cr | ₹3.41 Cr | ₹0.45 Cr |
What is the latest Total Non-Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹3.41 Cr |
| Mar2022 | ₹0.45 Cr |
How is Total Non-Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 138.92 | |
| Mar2024 | ₹13 Cr | 273.03 | |
| Mar2023 | ₹3.41 Cr | 652.98 | |
| Mar2022 | ₹0.45 Cr | - | |
Compare Total Non-Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹313.8 Cr | 1.5% | 6.4% | -6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 1.5% |
6.4% |
-6.6% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses